Midgard Science

Adimab

Lebanon, NH, United States adimab.com From their website, Nov 2026

Work here? Claim this listing

About

Adimab develops and engineers therapeutic biologics, with a focus on antibodies, multispecifics, and TCR-based proteins. It works with biopharma partners on discovery, engineering, and platform transfer from its operations in Lebanon, New Hampshire, and Mountain View, California.

Services

  • Antibody discovery

    Develops therapeutic IgG and HCAb leads using fully human synthetic and immune libraries and a yeast-based platform.

  • Antibody engineering

    Optimizes antibodies for specificity, affinity, stability, and developability across formats.

  • Multispecific antibodies and T cell engagers

    Designs and assembles bispecific and higher-order multispecific antibodies and T cell engagers.

  • Protein and TCR engineering

    Engineers soluble TCRs and other non-antibody proteins for binding, stability, specificity, and expression.

  • Funded discovery programs

    Runs discovery and optimization projects for therapeutic proteins with Adimab scientists and delivers characterized antibody panels.

  • Platform transfer

    Transfers Adimab’s yeast-based discovery platform into partner laboratories with training and ongoing support.

  • Non-exclusive programs

    Provides validated discovery and engineering modules that can be used with existing workflows.

  • Funded discovery

    Discovers antibody leads on Adimab’s platform and transfers them to partners for further development.

Turnaround
Within four months
What to send
Antigen inputs, including soluble, membrane-associated, membrane-spanning proteins, peptides, and glycans

Capabilities

Assays and studies
  • Antibodies
  • Bispecifics
  • Flow cytometry
  • Peptides
  • In vivo
  • Rodent models
17 more
  • CHO
  • MACS
  • FACS
  • Redirected cytotoxicity assay
  • Cytokine assay
  • Binding kinetics
  • Purity analysis
  • Functional testing
  • Cross-reactivity assessment
  • pH dependence assessment
  • Polyspecificity assessment
  • Real-time screening
  • Directed evolution
  • Deep mutational scanning
  • Cell-based function assay
  • Kinetic analysis
  • Analytical testing
Scale and capacity
  • 140+ biopharma partnerships
  • 675+ therapeutic programs initiated
  • 90+ clinical programs initiated
  • 6 commercial products
  • 85+ molecules advanced to clinic
  • More than 1,000 antibodies optimized
3 more
  • More than 200 internal programs
  • Over a thousand optimized antibodies
  • Dozens of receptors and peptide–HLA complexes
Therapeutic areas
  • Biopharma
  • Therapeutic biologics
  • All disease areas
  • Oncology

Instruments and platforms

  • Flow cytometry
  • MACS
  • FACS

Modalities and species

Modalities
  • Antibody
  • Bispecific
  • Peptide
Species and models
  • Yeast
  • Llama
  • CHO cells
  • HEK cells
  • Mice

Industries served

  • Biopharma

Company

Type
CRDMO
Founded
2007

Locations

Address
7 Lucent Drive Lebanon, NH 03766 USA
Sites
Mountain View, USA
Serves
Worldwide

Contacts

Similar labs